Abstract
Contrasting images: A new T1 contrast agent for magnetic resonance imaging (MRI) based on MnO nanoparticles reveals a bright signal enhancement and fine anatomic structures in the T1-weighted MR image of a mouse brain (see picture; left MRI, right MnO-enhanced MRI (MONEMRI)). Furthermore, MnO nanoparticles conjugated with a tumor-specific antibody were used for selectively imaging breast cancer cells in a metastatic tumor in brain. (Figure Presented).
| Original language | English |
|---|---|
| Pages (from-to) | 5397-5401 |
| Number of pages | 5 |
| Journal | Angewandte Chemie - International Edition |
| Volume | 46 |
| Issue number | 28 |
| DOIs | |
| State | Published - 2007 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Contrast agents
- Imaging agents
- Magnetic resonance imaging
- Manganese
- Nanoparticles
Fingerprint
Dive into the research topics of 'Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver